Johnson & Johnson Newsroom

Johnson & Johnson Analyst Ratings

BenzingaSep 23 20:50

RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target

BenzingaSep 20 21:32

RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $175

Futu NewsSep 20 19:31

Johnson & Johnson (JNJ) Gets a Buy From RBC Capital

TipRanksSep 20 18:55

Johnson & Johnson Analyst Ratings

BenzingaSep 19 22:40

Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

BenzingaSep 19 22:40

Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215

Futu NewsSep 19 20:31

Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating

Futu NewsSep 18 19:31

Johnson & Johnson Analyst Ratings

BenzingaSep 16 20:20

Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating

Futu NewsSep 12 05:32

Johnson & Johnson Analyst Ratings

BenzingaSep 9 20:55

Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

BenzingaSep 9 20:54

Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215

Futu NewsSep 9 20:31

Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215

Futu NewsSep 3 20:31

The latest pharmaceutical industry rating by S&P reveals that Johnson & Johnson (JNJ.US) and Roche (RHHBY.US) are ranked at the top for superior financial and innovative abilities.

Zhitong FinanceAug 19 11:30

Leerink Partners Maintains Johnson & Johnson(JNJ.US) With Buy Rating

Futu NewsAug 13 22:31

Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $169

Futu NewsAug 13 20:33

Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

BenzingaAug 6 02:07

Johnson & Johnson Analyst Ratings

BenzingaAug 6 02:07

Cantor Fitzgerald Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $215

Futu NewsJul 31 04:31